Condition: Cholecystectomy, Laparoscopic · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Gallstone is a common disease in China.At present, the prevalence of gallstones in China is 15 %, and about 210 million people are sick. Acute cholecystitis is acute gallbladder inflammation, is one of the main complications of cholelithiasis or gallstones. The removal of gallbladder and gallstones in patients with acute cholecystitis in the presence of biliary pain will prevent the recurrence of gallbladder and reduce the risk of cholecystitis progression. If gallbladder perforation is not treated in time, the mortality rate is 30 %. Acute acalculous cholecystitis without treatment will be life-threatening, with a mortality rate of up to 50 %. At present, the vast majority of patients with acute cholecystitis are treated with 4-hole traditional laparoscopic cholecystectomy and open cholecystectomy. Their postoperative quality of life, pain and scar-related complications, remain major factors for patients.In recent years, with the renewal of the concept of minimally invasive surgery and the continuous advancement of instruments and technology, single-incision laparoscopic cholecystectomy has also maximized the quality of life after surgery and reduced postoperative pain and scar-related complications. At present, there are few reports on randomized controlled clinical trials of SILC in patients with acute cholecystitis, and there is a lack of large sample size studies.Due to the difficulty of SILC operation, the longer learning curve, the different equipment conditions and te…
This description comes directly from the study's public registry record.
Liu Daren, MD, PhD · +86-15968179036 · darenliu@zju.edu.cn
Zha Liufan, MD, PhD · +86-18969952245 · liufanZha@outlook.com
Always discuss trial participation with your own doctor first.
| Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Huangshan City, Anhui, China | Recruiting |
| 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China | Hangzhou, Zhejiang, China | Recruiting |
| Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Huzhou, Zhejiang, China | Recruiting |
| Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Lishui, Zhejiang, China | Recruiting |
| Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University | Meicheng, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06074679